Verve

Eli Lilly reported positive interim Phase 1b data for its in vivo PCSK9 base editor VERVE-102, showing single-dose LDL-C reductions of up to 62% sustained for 18 months in patients with heterozygous f…

AdExchanger’s editorial team debated the shifting definition of “premium” content at Programmatic AI in Las Vegas, arguing that AI-generated slop and user engagement are blurring the line between high…

AppGoblin's 2026 Q1 App Ecosystem Report shows Verve leading ad networks for a second consecutive quarter, while Snap Inc., TaurusX, and adjoe also posted strong growth. In business tools, Luciq and P…